Quest Diagnostics Inc. (DGX)

100.90
NYSE : Health Services
Prev Close 101.28
Day Low/High 100.18 / 101.36
52 Wk Low/High 78.95 / 116.49
Avg Volume 1.08M
Exchange NYSE
Shares Outstanding 134.38M
Market Cap 13.61B
EPS 5.40
P/E Ratio 19.40
Div & Yield 2.12 (2.05%)

RBC Healthcare Conf.

Don't Pass on This Test Company

Don't Pass on This Test Company

Quest Diagnostics -- and others in this beaten-down sector -- are excellent trading vehicles.

Quest Diagnostics upgraded at Maxim

Quest Diagnostics numbers raised at UBS

Court Ruling Boosts Bio-Reference

Court Ruling Boosts Bio-Reference

Bio-Reference Labs CEO Dr. Marc Grodman says the Supreme Court ruling against human gene patents means big things for the testing industry.

Jefferies Healthcare Conf.

Quest Diagnostics upgraded at Goldman

Don't Let Bargain Prices Scare You Away

Don't Let Bargain Prices Scare You Away

It's much tougher to actually "buy low to sell high" than it is to espouse the concept.

Quest Diagnostics Could Be Your Golden Lab

Quest Diagnostics Could Be Your Golden Lab

The fear of 'dead money' has brought Quest back to an extremely low-risk entry point.

Dividend Diva

I execute a dividend-rotation strategy, trading in and out of stocks to capture the dividend payment. Those of you who also read the Real Money site know me as the "Dividend Diva." In one of my partnerships, I execute a dividend-rotation strategy, t...

DGX Investor Mtg.

Nose Jobs Take a Nosedive

Nose Jobs Take a Nosedive

Names tied to the cosmetic medical market will be vulnerable until consumer sentiment and disposable income rebound.

Likely Healthcare Victors

If the healthcare plan stands, these names stand to reap rich rewards.

Short Opportunity in Quest Diagnostics

Short Opportunity in Quest Diagnostics

This is a speculative trade, and preserving capital is job one.

DGX Investor Mtg.

A Hopeful Diagnosis

This healthcare name is moving bullishly, so let's figure out how to play it.

Not in the Clear Yet

Not in the Clear Yet

Volatility has retraced, but will remain with earnings reports coming fast and furious this week.

Analyst Actions -- 10/26/2011

Here are today's top research calls.

Analyst Actions -- 10/11/2011

Here are today's top research calls.

Analyst Actions -- 9/23/2011

Here are today's top research calls.